8078586 |
Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia
Bonaventure, J,
Munnich, A,
Rousseau, F,
Legeai-Mallet, L,
Rozet, JM,
Le Merrer, M,
Pelet, A,
Maroteaux, P
|
Nature |
1994 |
11055896 |
Distinct missense mutations of the FGFR3 lys650 codon modulate receptor kinase activation and the severity of the skeletal dysplasia phenotype
Francomano, CA,
Spector, EB,
Bellus, GA,
Garber, AT,
Israel, J,
Bryke, CR,
Speiser, PW,
Donoghue, DJ,
Weaver, CA,
Webster, MK,
Rosengren, SS
|
Am J Hum Genet |
2000 |
19066716 |
FGFR3-related dwarfism and cell signaling
Seino, Y,
Tanaka, H,
Ueda, K,
Yamanaka, Y,
Harada, D
|
J Bone Miner Metab |
2009 |
9865713 |
High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) in patients with plasma cell malignancies
Harousseau, JL,
Talmant, P,
Li, JY,
Avet-Loiseau, H,
Jaccard, A,
Facon, T,
Bataille, R,
Rapp, MJ,
Morineau, N,
Trimoreau, F,
Maloisel, F,
Brigaudeau, C
|
Cancer Res |
1998 |
25246530 |
TACC3 protein regulates microtubule nucleation by affecting γ-tubulin ring complexes
Gireesh, KK,
Singh, P,
Manna, TK,
Thomas, GE
|
J. Biol. Chem. |
2014 |
19749790 |
Mutant fibroblast growth factor receptor 3 induces intracellular signaling and cellular transformation in a cell type- and mutation-specific manner
Knowles, MA,
di Martino, E,
L'Hote, CG,
Tomlinson, DC,
Kennedy, W
|
Oncogene |
2009 |
7647778 |
Stop codon FGFR3 mutations in thanatophoric dwarfism type 1
Bonaventure, J,
Munnich, A,
Narcy, F,
Rousseau, F,
Sanak, M,
Saugier, P,
Le Merrer, M,
Delezoide, AL,
Maroteaux, P
|
Nat Genet |
1995 |
10053006 |
A novel skeletal dysplasia with developmental delay and acanthosis nigricans is caused by a Lys650Met mutation in the fibroblast growth factor receptor 3 gene
Wilcox, WR,
Jabs, EW,
Bellus, GA,
Bamshad, MJ,
Wasmuth, JJ,
Donoghue, DJ,
Jiang, W,
Fraley, AE,
Francomano, CA,
Thompson, LM,
McIntosh, I,
Szabo, J,
Webster, MK,
Tavormina, PL
|
Am J Hum Genet |
1999 |
8845844 |
Missense FGFR3 mutations create cysteine residues in thanatophoric dwarfism type I (TD1)
Bonaventure, J,
Munnich, A,
El Ghouzzi, V,
Rousseau, F,
Legeai-Mallet, L,
Le Merrer, M,
Delezoide, AL
|
Hum Mol Genet |
1996 |
7670477 |
A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia
Greenhaw, GA,
Francomano, CA,
Hecht, JT,
Bellus, GA,
Horton, WA,
Aylsworth, AS,
McIntosh, I,
Kaitila, I,
Smith, EA
|
Nat Genet |
1995 |
8841188 |
Identical mutations in three different fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromes
Francomano, CA,
Clarke, LA,
Bellus, GA,
Zackai, EH,
Muenke, M,
Szabo, J,
Gaudenz, K
|
Nat Genet |
1996 |
10471491 |
Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas
Sastre-Garau, X,
de Medina, S,
Chopin, D,
Radvanyi, F,
Bourdin, J,
Thiery, JP,
Ricol, D,
Cappellen, D,
De Oliveira, C
|
Nat Genet |
1999 |
9438390 |
Constitutive activation of fibroblast growth factor receptor 3 by mutations responsible for the lethal skeletal dysplasia thanatophoric dysplasia type I
Bardwell, WM,
Donoghue, DJ,
d'Avis, PY,
Robertson, SC,
Webster, MK,
Meyer, AN
|
Cell Growth Differ |
1998 |
21711248 |
Fibroblast growth factors and their receptors in cancer
Haglund, K,
Wesche, J,
Haugsten, EM
|
Biochem J |
2011 |
9538690 |
Fibroblast growth factor receptors: lessons from the genes
Burke, D,
Malcolm, S,
Blundell, TL,
Wilkes, D
|
Trends Biochem Sci |
1998 |
9154000 |
FGFR activation in skeletal disorders: too much of a good thing
Donoghue, DJ,
Webster, MK
|
Trends Genet |
1997 |
8589699 |
Another mutation that results in the substitution of an unpaired cysteine residue in the extracellular domain of FGFR3 in thanatophoric dysplasia type I
Cohn, DH,
Wasmuth, JJ,
Shiang, R,
Rimoin, DL,
Zhu, YZ,
Tavormina, PL
|
Hum Mol Genet |
1995 |
23558953 |
Identification of targetable FGFR gene fusions in diverse cancers
Kalyana-Sundaram, S,
Chinnaiyan, AM,
Wang, R,
Tomlins, SA,
Ateeq, B,
Cao, X,
Cheng, AJ,
Rhodes, DR,
Hussain, MH,
Kunju, LP,
Lonigro, RJ,
Robinson, DR,
Sadis, S,
Talpaz, M,
Lin, SF,
Pienta, KJ,
Feng, FY,
Roychowdhury, S,
Vats, P,
Wu, YM,
Wyngaard, P,
Su, F,
Khazanov, N,
Siddiqui, J,
Zalupski, MM
|
Cancer Discov |
2013 |
23298836 |
The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma
Parker, BC,
Sun, Y,
Granberg, KJ,
Zhang, W,
Liu, CG,
Ji, P,
Zheng, H,
Li, X,
Lang, FF,
Haapasalo, H,
Nykter, M,
Cogdell, DE,
Gumin, J,
Chen, K,
Liu, X,
Hu, L,
Sawaya, R,
Annala, MJ,
Fuller, GN,
Yli-Harja, O,
Visakorpi, T
|
J. Clin. Invest. |
2013 |
11466624 |
Frequency of fibroblast growth factor receptor 3 mutations in sporadic tumours
Knowles, MA,
Sibley, K,
Stern, P
|
Oncogene |
2001 |
7847369 |
Achondroplasia is defined by recurrent G380R mutations of FGFR3
Machado, M,
Francomano, CA,
Hecht, JT,
Bellus, GA,
Ortiz de Luna, RI,
McIntosh, I,
Horton, WA,
Kaitila, I,
Hefferon, TW
|
Am J Hum Genet |
1995 |
24588013 |
Emergence of FGFR family gene fusions as therapeutic targets in a wide spectrum of solid tumours
Parker, BC,
Zhang, W,
Annala, M,
Engels, M
|
J. Pathol. |
2014 |
15282208 |
Biochemical analysis of pathogenic ligand-dependent FGFR2 mutations suggests distinct pathophysiological mechanisms for craniofacial and limb abnormalities
Eliseenkova, AV,
Linhardt, RJ,
Itoh, N,
Zhang, F,
Mohammadi, M,
Ibrahimi, OA
|
Hum Mol Genet |
2004 |
7913883 |
Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia
Winokur, ST,
Wasmuth, JJ,
Thompson, LM,
Bocian, M,
Fielder, TJ,
Shiang, R,
Church, DM,
Zhu, YZ
|
Cell |
1994 |
9279753 |
Craniosynostosis associated with FGFR3 pro250arg mutation results in a range of clinical presentations including unisutural sporadic craniosynostosis
Rutland, P,
Hall, CM,
Winter, RM,
Hayward, R,
Pulleyn, LJ,
Dean, JC,
Nevin, NC,
Baraister, M,
Evans, RD,
Jones, BM,
Reardon, W,
Malcolm, S,
Wilkes, D
|
J Med Genet |
1997 |
24850843 |
FGFR1/3 tyrosine kinase fusions define a unique molecular subtype of non-small cell lung cancer
Luo, X,
Sun, Y,
Ye, T,
Zhang, J,
Shen, L,
Pan, B,
Pan, Y,
Li, Y,
Li, B,
Chen, H,
Zhang, Y,
Wang, R,
Ji, H,
Wang, L,
Li, H,
Zhang, Y,
Shen, X,
Hu, H,
Pao, W
|
Clin. Cancer Res. |
2014 |
7773297 |
Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3
Wilcox, WR,
Lachman, RS,
Cohn, DH,
Wasmuth, JJ,
Thompson, LM,
Wilkin, DJ,
Rimoin, DL,
Shiang, R,
Zhu, YZ,
Tavormina, PL
|
Nat Genet |
1995 |
25535896 |
Recurrent FGFR3-TACC3 fusion gene in nasopharyngeal carcinoma
Zeng, MS,
Yuan, L,
Liu, ZH,
Lin, ZR,
Zhong, Q,
Xu, LH
|
Cancer Biol. Ther. |
2014 |
10377013 |
Severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN): phenotypic analysis of a new skeletal dysplasia caused by a Lys650Met mutation in fibroblast growth factor receptor 3
Lachman, RS,
Wilcox, WR,
Jabs, EW,
Przylepa, KA,
Francomano, CA,
Curry, CJ,
Bellus, GA,
Bamshad, MJ,
Lee, RR,
Rimoin, DL,
Hurko, O,
Dorst, J
|
Am J Med Genet |
1999 |
23175443 |
Oncogenic FGFR3 gene fusions in bladder cancer
Knowles, MA,
Williams, SV,
Hurst, CD
|
Hum. Mol. Genet. |
2013 |
8640234 |
Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia
Ornitz, DM,
Wang, Q,
Xu, J,
Naski, MC
|
Nat Genet |
1996 |
9207791 |
Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3
Kuehl, WM,
Nardini, E,
Chesi, M,
Brents, LA,
Schröck, E,
Bergsagel, PL,
Ried, T
|
Nat Genet |
1997 |